NCT04776902 (EROSS) is a NA clinical trial of Survey in Sex Behavior, sponsored by Uludag University.

Who is sponsoring NCT04776902?

NCT04776902 is sponsored by Uludag University.

What drugs are being tested in NCT04776902?

Interventions in NCT04776902: Survey.

What condition does NCT04776902 study?

NCT04776902 studies Sex Behavior, Ovarian Failure.

Is NCT04776902 still recruiting?

NCT04776902 is currently completed. Last updated 13 June 2022.

Last reviewed 2022-06-13 · How we verify

NCT04776902: EROSS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Ovarian Reserve on Sexual Satisfaction

Completed NA Last updated 13 June 2022

What this trial tests

NA trial testing Survey in Sex Behavior in 180 participants. Completed in 1 June 2021.

Timeline

1 October 2020

Primary endpoint
1 May 2021

1 June 2021

Quick facts

Lead sponsor	Uludag University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	180
Start date	1 October 2020
Primary completion	1 May 2021
Estimated completion	1 June 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Survey

Conditions studied

Sex Behavior — all drugs for Sex Behavior →
Ovarian Failure — all drugs for Ovarian Failure →

Sponsor

Uludag University

Who can join

Adults 18 to 45, female only, with Sex Behavior or Ovarian Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a survey study. The primary aim of the study is to investigate the relationship between the ovarian reserve and sexual satisfaction. All the patients who underwent ovarian reserve assessment for any reason will fill a questionnaire about sexual satisfaction. And the survey results will be compared with patients' ovarian reserve.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

EROSS study: effect of ovarian reserve on sexual satisfaction.
Kulahci Aslan E, Aslan K, Gurluler J, Uyaniklar O, et al · · 2022 · cited 1× · PMID 35666951 · DOI 10.1080/01443615.2022.2081798

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
NCT07294703 — Factors Associated With Breast Cancer Risks and Outcomes · recruiting
NCT07330739 — Kinesiophobia in Women With Stress Urinary Incontinence · active not recruiting
NCT07215039 — Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida · enrolling by invitation
NCT07220096 — Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Pati · recruiting

Other recruiting trials for Sex Behavior

Currently open trials in the same condition.

NCT04331704 — ANCHORS Alcohol & Sexual Health Study: UH3 Project · Phase 4 · recruiting

Other Uludag University trials

Trials by the same sponsor.

NCT07478601 — Effect of Erector Spinae Plane Block on Postoperative Respiratory Function After Laparoscopic Cholecystectomy · NA · not yet recruiting
NCT07440615 — Lower-Limb Muscle Mass and Cardiovascular and Muscular Performance in Males and Females · NA · not yet recruiting
NCT07393620 — Predictive Value of aEEG and Cerebral Oxygenation on Neurological Outcomes in Newborns With Mild Hypoxic-Ischemic Enceph · not yet recruiting
NCT07350018 — Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome · Phase 4 · not yet recruiting
NCT07365605 — Lower-Limb Muscle Mass and Balance Performance · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04776902 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uludag University
Last refreshed: 13 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing